Cue Biopharma, Inc.CUENASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank40
3Y CAGR-19.3%
5Y CAGR-18.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-19.3%/yr
vs +25.5%/yr prior
5Y CAGR
-18.4%/yr
Consistent
Acceleration
-44.8pp
Decelerating
Percentile
P40
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $27.14M | +20.8% |
| 2024 | $22.46M | -53.7% |
| 2023 | $48.51M | -6.0% |
| 2022 | $51.61M | -19.8% |
| 2021 | $64.37M | -14.0% |
| 2020 | $74.87M | +69.0% |
| 2019 | $44.29M | +112.9% |
| 2018 | $20.80M | -67.3% |
| 2017 | $63.53M | +325.7% |
| 2016 | $14.93M | - |